GlucoTrack Inc. Stock Skyrockets 40% Following Successful Glucose Monitor Trial
GlucoTrack Inc.’s stock price surged 40% after the company announced positive results from its first-in-human clinical trial for an implantable blood glucose monitor.
2 minutes to read